Skip to main content
Top

03-17-2017 | Primary care | News

News in brief

Positive spillover effects from drive to improve diabetes primary care

print
PRINT
insite
SEARCH

medwireNews: A drive to improve the care of screen-detected diabetes patients in primary care appears to also result in better outcomes for high-risk patients without diabetes.

A total of 11,224 patients in the ADDITION-Denmark study were normoglycemic, despite screening as high-risk for diabetes. But these patients belonged to primary practices that had been randomly assigned to receive training and support to deliver intensive, comprehensive diabetes treatment and education to their patients.

Compared with 10,289 patients in practices that continued to deliver routine care to their diabetes patients, those in the intensive-care practices had a significant 8% reduction in cardiovascular disease risk during the 10 years of the study. The effect was most pronounced among patients at high cardiovascular risk, at a 15% reduction in risk.

However, Rebecca Simmons (University of Cambridge, UK) and co-researchers note that patients were generally undertreated, even the high-risk group. “We suggest that the reduction in cardiovascular events might have been greater if general practitioners were convinced to treat according to guidelines for cardiovascular risk management,” they write in Diabetologia.

By Eleanor McDermid

medwireNews is an independent medical news service provided by Springer Healthcare. © 2017 Springer Healthcare part of the Springer Nature group


Read the full research paper here.


print
PRINT

Novel clinical evidence in continuous glucose monitoring

Novel clinical evidence in continuous glucose monitoring

How real-world studies complement randomized controlled trials

Jean-Pierre Riveline uses data from real-life continuous glucose monitoring studies to illustrate how these can uncover critical information about clinical outcomes that are hard to assess in randomized controlled trials.

This video has been developed through unrestricted educational funding from Abbott Diabetes Care.

Watch the video